---  
layout: startup_page  
title: "ONCOMATRYX"  
id: "oncomatryx.com"  
permalink: "/oncomatryxoncomatryx.com01272025/"  
website: "https://oncomatryx.com/"  
funding_round: ""  
funding_amount: "€25M"  
investors: "Existing investors, Centro para el Desarrollo Tecnológico y la Innovación"  
about: "ONCOMATRYX is a biopharmaceutical company developing novel Antibody-Drug Conjugates (ADCs) targeting the tumor microenvironment, specifically Cancer-Associated Fibroblasts (CAFs). Their lead product, OMTX705, is a first-in-class ADC targeting Fibroblast Activation Protein (FAP) and is currently in Phase Ib-II clinical trials. The company collaborates with universities, hospitals, and research centers in the US and Europe."  
markets: "Biopharmaceutical, Oncology, Antibody-Drug Conjugates (ADCs)"  
hq: "Derio, Bizkaia, Spain"  
founded_year: "2009"  
linkedin: "https://www.linkedin.com/company/oncomatryx-biopharma"  
twitter: "https://twitter.com/oncomatryx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/oncomatryx"  
pitchbook: "https://pitchbook.com/profiles/company/221763-34"  

date_display: "27-Jan-2025"  
date: "2025-01-27"

# SEO Optimization  
meta_title: "ONCOMATRYX -  Funding (€25M)"  
meta_description: "ONCOMATRYX, ONCOMATRYX is a biopharmaceutical company developing novel Antibody-Drug Conjugates (ADCs) targeting the tumor microenvironment, specifically Cancer-A..."  
meta_keywords: "ONCOMATRYX, Biopharmaceutical, Oncology, Antibody-Drug Conjugates (ADCs),  funding"  
canonical_url: "https://startup.projectstartups.com/oncomatryxoncomatryx.com01272025/"  
---